Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats
- PMID: 32033424
- PMCID: PMC7076358
- DOI: 10.3390/pharmaceutics12020134
Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats
Erratum in
-
Correction: López-Yerena, A., et al. "Absorption and Intestinal Metabolic Profile of Oleocanthal in Rats" Pharmaceutics 2020, 12, 134.Pharmaceutics. 2020 Dec 17;12(12):1220. doi: 10.3390/pharmaceutics12121220. Pharmaceutics. 2020. PMID: 33348931 Free PMC article.
Abstract
Oleocanthal (OLC), a phenolic compound of extra virgin olive oil (EVOO), has emerged as a potential therapeutic agent against a variety of diseases due to its anti-inflammatory activity. The aim of the present study is to explore its in vivo intestinal absorption and metabolism. An in situ perfusion technique in rats was used, involving simultaneous sampling from the luminal perfusate and mesenteric blood. Samples were analysed by UHPLC-MS-MS for the presence of oleocanthal (OLC) and its metabolites. OLC was mostly metabolized by phase I metabolism, undergoing hydration, hydrogenation and hydroxylation. Phase II reactions (glucuronidation of hydrogenated OLC and hydrated metabolites) were observed in plasma samples. OLC was poorly absorbed in the intestine, as indicated by the low effective permeability coefficient (2.23 ± 3.16 × 10-5 cm/s) and apparent permeability coefficient (4.12 ± 2.33 × 10-6 cm/s) obtained relative to the values of the highly permeable reference compound levofloxacin (LEV). The extent of OLC absorption reflected by the area under the mesenteric blood-time curve normalized by the inlet concentration (AUC) was also lower than that of LEV (0.25 ± 0.04 vs. 0.64 ± 0.03, respectively). These results, together with the observed intestinal metabolism, suggest that OLC has a moderate-to-low oral absorption; but higher levels of OLC are expected to reach human plasma vs. rat plasma.
Keywords: bioavailability; extra virgin olive oil; in situ perfusion; metabolism; permeability; secoiridoids.
Conflict of interest statement
R.M.L.-R. reports receiving lecture fees from Cerveceros de España and receiving lecture fees and travel support from Adventia. The other authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Montedoro G., Servili M., Baldioli M., Selvaggini R., Miniati E., Macchioni A., Agrarie I., Costanzo V.S., Agrarie I., Chimica D. Simple and hydrolyzable compounds in virgin olive oil. 3. Spectroscopic Characterizations of the Secoiridoid Derivatives. J. Agric. Food Chem. 1993;41:2228–2234. doi: 10.1021/jf00035a076. - DOI
-
- Lozano-Castellón J., López-Yerena A., Rinaldi de Alvarenga J.F., Castillo-Alba J.R., Vallverdú-Queralt A., Escribano-Ferrer E., Lamuela-Raventós R.M. Health-promoting properties of oleocanthal and oleacein: Two secoiridoids from extra-virgin olive oil. Crit. Rev. Food Sci. Nutr. 2019:1–17. doi: 10.1080/10408398.2019.1650715. - DOI - PubMed
-
- Francisco V., Ruiz-Fernández C., Lahera V., Lago F., Pino J., Skaltsounis L., González-Gay M.A., Mobasheri A., Goámez R., Scotece M., et al. Natural Molecules for Healthy Lifestyles: Oleocanthal from Extra Virgin Olive Oil. J. Agric. Food Chem. 2019;67:3845–3853. doi: 10.1021/acs.jafc.8b06723. - DOI - PubMed
